These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24242681)

  • 21. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma.
    Sakai M; Suzuki S; Sano A; Tanaka N; Inose T; Sohda M; Nakajima M; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2012 Jun; 19(6):1911-7. PubMed ID: 22290569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
    Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M
    Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
    Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
    J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
    Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
    Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of Glut1 and c-myc on prognosis in esophageal squamous cell carcinoma of Kazakh and Han patients.
    Zhou YX; Zhou KM; Liu Q; Wang H; Wang W; Shi Y; Ma YQ
    Future Oncol; 2018 Aug; 14(18):1801-1815. PubMed ID: 29629851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
    Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
    Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
    Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma.
    Akutsu Y; Hanari N; Yusup G; Komatsu-Akimoto A; Ikeda N; Mori M; Yoneyama Y; Endo S; Miyazawa Y; Matsubara H
    Ann Surg Oncol; 2011 Oct; 18(10):2946-51. PubMed ID: 21437756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
    Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
    Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical significance of preoperative plasma fibrinogen level and platelet count in resectable esophageal squamous cell carcinoma.
    Wang J; Liu H; Shao N; Tan B; Song Q; Jia Y; Cheng Y
    World J Surg Oncol; 2015 Apr; 13():157. PubMed ID: 25896470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma.
    Nanashima A; Shibata K; Nakayama T; Tobinaga S; Araki M; Kunizaki M; Takeshita H; Hidaka S; Sawai T; Nagayasu T; Yasutake T
    Ann Surg Oncol; 2009 Aug; 16(8):2130-7. PubMed ID: 19495885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of thrombin receptor expression on microvessel endothelial cells, and survival by coagulation state in oesophageal squamous cell carcinoma.
    Shao Y; Xu QQ; Li C; Wu MY; Huang XY
    J Clin Pathol; 2012 Aug; 65(8):740-5. PubMed ID: 22685255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.
    Hoshino I; Matsubara H; Akutsu Y; Nishimori T; Yoneyama Y; Murakami K; Sakata H; Matsushita K; Ochiai T
    Oncol Rep; 2007 Oct; 18(4):867-71. PubMed ID: 17786348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma.
    Baek SK; Jung KY; Lee SH; Woo JS; Kwon SY; Chung EJ; Kim TH; Chae YS
    Laryngoscope; 2009 Jul; 119(7):1325-30. PubMed ID: 19444880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
    Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
    Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.